Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrogen Bromide | HCID 260 | — |
| Reactant | Naltrexone | HCID 5360515 | — |
| Reactant | Methylnaltrexone Bromide | HCID 5361917 | — |
| Product | 2-Naphthylalanine | HCID 185915 | — |
Reaction Steps
The entry for Example 4 in Table 3 represents the effect of the addition of acid (0.1 equiv. HBr). Incorporation of this reagent increased the yield of the product (naltrexone methobromide) to about 77.5% and decreased the side products to about 5.1%. Addition of HBr suppresses the ionization of the C(3) hydroxide (phenolic hydroxide) of naltrexone to form Nal (see Scheme 4) and thereby reduces the chemical reactivity of the C(3) hydroxide toward MeBr. Further, addition of a strong anhydrous acid (HBr) to the reaction system permits use of partially hydrated naltrexone (Naltrexone.2H2O) as a starting material instead of anhydrous naltrexone thereby eliminating the processing costs associated with dehydration of naltrexone. Since an additional reaction step is required to prepare anhydrous naltrexone from the hydrate (Naltrexone.2H2O), addition of HBr would reduce processing costs.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09415044B2 |
|---|
| Source dataset | uspto-grants-2016_08 |
|---|
| ORD ID | ord-b558ea5a76c9408a93c7bef9dd734d30 |
|---|
| Source note | uspto-grants-2016_08 |
|---|